Status:
COMPLETED
Mychoice: Testing an Interactive mHealth Tool
Lead Sponsor:
Fox Chase Cancer Center
Collaborating Sponsors:
Merck Sharp & Dohme LLC
University of Pennsylvania
Conditions:
Conflict
Decisional Conflict
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Investigators aim to test a culturally diverse and patient guided mHealth decision tool called mychoice, which allows patients to explore their concerns and questions related to clinical trial partici...
Detailed Description
Evidence shows that although clinical trials are aimed at producing new strategies for reducing cancer morbidity and mortality, participation remains sub-optimal for all populations, especially those ...
Eligibility Criteria
Inclusion
- 18 years of age or over
- Active diagnosis of invasive cancer (any diagnoses), pre or post chemo/radiation/surgery
- Able to speak and read English
Exclusion
- Participated in a therapeutic trial in the past
Key Trial Info
Start Date :
June 25 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2020
Estimated Enrollment :
257 Patients enrolled
Trial Details
Trial ID
NCT03427177
Start Date
June 25 2018
End Date
February 28 2020
Last Update
January 27 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
2
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States, 19107
3
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111
4
Temple University
Philadelphia, Pennsylvania, United States, 19121